The pharmaceutical leader has established itself as the leader in the fast-growing weight loss market. And although many ...
Zacks Investment Research on MSN
3 cancer stocks to buy amid rapid advances in cancer treatment
An updated edition of the October 28, 2025, article. The global oncology market is entering a period of significant evolution, supported by rising cancer incidence and rapid scientific advancement.
Eli Lilly and Company today announced positive topline results from the ATTAIN-MAINTAIN trial. The Phase 3 study evaluated orforglipron, an investigational, once-daily oral small molecule ...
Eli Lilly’s next-generation obesity treatment may prove highly effective for patients who have high BMI or suffer from ...
LLY's explosive GLP-1 growth, deep obesity pipeline and strong estimate momentum give it the edge over MRK despite a richer valuation.
Detailed price information for Eli Lilly and Company (LLY-N) from The Globe and Mail including charting and trades.
Verastem Oncology , a biopharmaceutical company committed to advancing new medicines for patients with RAS/MAPK pathway-driven cancers, today announced strategic leadership changes to accelerate its ...
Detailed price information for Eli Lilly and Company (LLY-N) from The Globe and Mail including charting and trades.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results